Literature DB >> 32979059

Radiomic analysis of magnetic resonance fingerprinting in adult brain tumors.

Sara Dastmalchian1, Ozden Kilinc1, Louisa Onyewadume2, Charit Tippareddy2, Debra McGivney3, Dan Ma3, Mark Griswold1,3, Jeffrey Sunshine1, Vikas Gulani4, Jill S Barnholtz-Sloan5, Andrew E Sloan6,7, Chaitra Badve8.   

Abstract

PURPOSE: This is a radiomics study investigating the ability of texture analysis of MRF maps to improve differentiation between intra-axial adult brain tumors and to predict survival in the glioblastoma cohort.
METHODS: Magnetic resonance fingerprinting (MRF) acquisition was performed on 31 patients across 3 groups: 17 glioblastomas, 6 low-grade gliomas, and 8 metastases. Using regions of interest for the solid tumor and peritumoral white matter on T1 and T2 maps, second-order texture features were calculated from gray-level co-occurrence matrices and gray-level run length matrices. Selected features were compared across the three tumor groups using Wilcoxon rank-sum test. Receiver operating characteristic curve analysis was performed for each feature. Kaplan-Meier method was used for survival analysis with log rank tests.
RESULTS: Low-grade gliomas and glioblastomas had significantly higher run percentage, run entropy, and information measure of correlation 1 on T1 than metastases (p < 0.017). The best separation of all three tumor types was seen utilizing inverse difference normalized and homogeneity values for peritumoral white matter in both T1 and T2 maps (p < 0.017). In solid tumor T2 maps, lower values in entropy and higher values of maximum probability and high-gray run emphasis were associated with longer survival in glioblastoma patients (p < 0.05). Several texture features were associated with longer survival in glioblastoma patients on peritumoral white matter T1 maps (p < 0.05).
CONCLUSION: Texture analysis of MRF-derived maps can improve our ability to differentiate common adult brain tumors by characterizing tumor heterogeneity, and may have a role in predicting outcomes in patients with glioblastoma.

Entities:  

Keywords:  Glioblastoma; Lower grade glioma; Magnetic resonance fingerprinting; Metastasis; Radiomics; Survival analysis; Texture analysis

Mesh:

Year:  2020        PMID: 32979059     DOI: 10.1007/s00259-020-05037-w

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

1.  Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.

Authors:  Andreas Wibmer; Hedvig Hricak; Tatsuo Gondo; Kazuhiro Matsumoto; Harini Veeraraghavan; Duc Fehr; Junting Zheng; Debra Goldman; Chaya Moskowitz; Samson W Fine; Victor E Reuter; James Eastham; Evis Sala; Hebert Alberto Vargas
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

2.  Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.

Authors:  Jacob A Miller; Elizabeth E Bennett; Roy Xiao; Rupesh Kotecha; Samuel T Chao; Michael A Vogelbaum; Gene H Barnett; Lilyana Angelov; Erin S Murphy; Jennifer S Yu; Manmeet S Ahluwalia; John H Suh; Alireza M Mohammadi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-01       Impact factor: 7.038

Review 3.  Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.

Authors:  Srishti Abrol; Aikaterini Kotrotsou; Ahmed Salem; Pascal O Zinn; Rivka R Colen
Journal:  Top Magn Reson Imaging       Date:  2017-02

4.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

5.  A multigene predictor of outcome in glioblastoma.

Authors:  Howard Colman; Li Zhang; Erik P Sulman; J Matthew McDonald; Nasrin Latif Shooshtari; Andreana Rivera; Sonya Popoff; Catherine L Nutt; David N Louis; J Gregory Cairncross; Mark R Gilbert; Heidi S Phillips; Minesh P Mehta; Arnab Chakravarti; Christopher E Pelloski; Krishna Bhat; Burt G Feuerstein; Robert B Jenkins; Ken Aldape
Journal:  Neuro Oncol       Date:  2009-10-20       Impact factor: 12.300

6.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  Adult IDH wild-type lower-grade gliomas should be further stratified.

Authors:  Abudumijit Aibaidula; Aden Ka-Yin Chan; Zhifeng Shi; Yanxi Li; Ruiqi Zhang; Rui Yang; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Yu Yao; Liangfu Zhou; Jinsong Wu; Hong Chen; Ho-Keung Ng
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

Review 8.  Molecular heterogeneity in glioblastoma: potential clinical implications.

Authors:  Nicole Renee Parker; Peter Khong; Jonathon Fergus Parkinson; Viive Maarika Howell; Helen Ruth Wheeler
Journal:  Front Oncol       Date:  2015-03-03       Impact factor: 6.244

9.  Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.

Authors:  Olya Grove; Anders E Berglund; Matthew B Schabath; Hugo J W L Aerts; Andre Dekker; Hua Wang; Emmanuel Rios Velazquez; Philippe Lambin; Yuhua Gu; Yoganand Balagurunathan; Edward Eikman; Robert A Gatenby; Steven Eschrich; Robert J Gillies
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  5 in total

1.  Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study.

Authors:  Charit Tippareddy; Louisa Onyewadume; Andrew E Sloan; Gi-Ming Wang; Nirav T Patil; Siyuan Hu; Jill S Barnholtz-Sloan; Rasim Boyacıoğlu; Vikas Gulani; Jeffrey Sunshine; Mark Griswold; Dan Ma; Chaitra Badve
Journal:  Eur Radiol       Date:  2022-08-24       Impact factor: 7.034

Review 2.  A Systematic Review of the Current Status and Quality of Radiomics for Glioma Differential Diagnosis.

Authors:  Valentina Brancato; Marco Cerrone; Marialuisa Lavitrano; Marco Salvatore; Carlo Cavaliere
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  MR Fingerprinting-A Radiogenomic Marker for Diffuse Gliomas.

Authors:  Elisabeth Springer; Pedro Lima Cardoso; Bernhard Strasser; Wolfgang Bogner; Matthias Preusser; Georg Widhalm; Mathias Nittka; Gregor Koerzdoerfer; Pavol Szomolanyi; Gilbert Hangel; Johannes A Hainfellner; Wolfgang Marik; Siegfried Trattnig
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.575

Review 4.  Beyond Glioma: The Utility of Radiomic Analysis for Non-Glial Intracranial Tumors.

Authors:  Darius Kalasauskas; Michael Kosterhon; Naureen Keric; Oliver Korczynski; Andrea Kronfeld; Florian Ringel; Ahmed Othman; Marc A Brockmann
Journal:  Cancers (Basel)       Date:  2022-02-07       Impact factor: 6.639

5.  Accelerated 3D whole-brain T1, T2, and proton density mapping: feasibility for clinical glioma MR imaging.

Authors:  Bjoern H Menze; Marion I Menzel; Juan A Hernandez-Tamames; Carolin M Pirkl; Laura Nunez-Gonzalez; Florian Kofler; Sebastian Endt; Lioba Grundl; Mohammad Golbabaee; Pedro A Gómez; Matteo Cencini; Guido Buonincontri; Rolf F Schulte; Marion Smits; Benedikt Wiestler
Journal:  Neuroradiology       Date:  2021-04-09       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.